Table 3.
Antifungal power of EOAG as assessed by use of inhibition zone diameters and MIC assays.
| C. albicans | A. niger | A. flavus | F. oxysporum | ||
|---|---|---|---|---|---|
| EOAG | Inhibition diameter (mm) | 26.41 ± 1.90 a | 17.01 ± 1.08 b | 16.76 ± 1.02 b | 33.62 ± 2.14 c |
| MIC (µg/mL) | 19.39 ± 1.0 a | 24.50 ± 1.30 b | 23.74 ± 1.81 b | 18.29 ± 1.21 a | |
| Flu | Inhibition diameter | 0 a | 11.41 ± 1.31 b | 0 a | 16.18 ± 2.43 c |
| MIC (µg/mL) | 0 a | 10.27 ± 0.84 b | 0 a | 33.12 ± 1.38 c | |
Row values with different letters differed significantly (one-way ANOVA; Tukey test, p < 0.05). MIC: minimum inhibitory concentration; Staphylococcus aureus ATCC 6633; Escherichia coli K12; Bacillus subtilis DSM 6333; Pseudo-monas aeruginosa CIP A22; Stp: Streptomycin; Kan: Kanamycin; R: Resistant; C.A: Candida albicans ATCC 10231; Aspergillus niger MTCC 282; Aspergillus flavus MTCC 9606; Fusarium oxysporum MTCC 9913; Flu: Fluconazole.